Related Experiment Videos
Summary
Extensive toxicological studies show clobazam has a wide range of LD50 values across species. Long-term use in animals revealed withdrawal effects, but overall preclinical safety was demonstrated.
Area of Science:
- Pharmacology and Toxicology
- Preclinical Drug Safety Assessment
Background:
- Clobazam is a benzodiazepine medication.
- Understanding its toxicological profile is crucial for safe clinical use.
Purpose of the Study:
- To summarize extensive toxicological investigations of clobazam.
- To assess the safety and tolerability of clobazam in preclinical animal studies.
Main Methods:
- Oral administration of clobazam to various animal species.
- Acute toxicity testing to determine LD50 values.
- Long-term repeated dose studies in dogs and monkeys.
Main Results:
- Oral LD50 values varied significantly, from 100 mg/kg in dogs to 6000 mg/kg in rats.
- Long-term studies identified withdrawal effects, including fatal convulsions in dogs and monkeys, consistent with other benzodiazepines.
- Preclinical data indicate a defined safety profile for clobazam.
Conclusions:
- The toxicological profile of clobazam has been extensively characterized in animal models.
- While withdrawal effects are noted, the overall safety and tolerability are supported by preclinical data.
- These findings contribute to the understanding of clobazam's safety in its developmental stages.